The accomplished global business executive will oversee the firm\'s strategic growth initiatives for the Asia-Pacific region.
The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting dose was generally well tolerated in this open-label trial.
TOKYO,Feb. 13,2025-- The global energy sector is gearing up for one of the most anticipated events of the year. From February 19 to 21,2025,Ampace and TDK will jointly exhibit at Tokyo Big Sight (Boot
TOKYO,Feb. 13,2025--TOYO Co.,Ltd (Nasdaq: TOYO) ("TOYO" or the "Company"),a solar solution company,today announced its participation in upcoming industry and investment conferences
NEW YORK,Feb. 13,2025-- SunCar Technology Group Inc. ("SunCar" or the "Company") (NASDAQ: SDA),an innovative leader in auto e-insurance and cloud-based B2B auto services in China,t
NEW YORK,Feb. 13,2025-- In an era of rapid digital transformation,global technology intelligence firm ABI Research has released its highly anticipated 66 Must-Know Tech Stats for 2025: Markets on the
